(Circulation. 2000;101:2783.)
© 2000 American Heart Association, Inc.
Clinical Investigation and Reports |
Association of a T29
C Polymorphism of the Transforming Growth Factor-ß1 Gene With Genetic Susceptibility to Myocardial Infarction in Japanese
From the Department of Clinical Laboratory Medicine (M.Y., T.-L.L., N.N.) and First Department of Internal Medicine (S.I.), Nagoya University School of Medicine, Nagoya, Japan, and Department of Geriatric Research (Y.Y.), National Institute for Longevity Sciences, Obu, Japan.
Correspondence to Mitsuhiro Yokota, MD, PhD, Department of Clinical Laboratory Medicine, Nagoya University School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8560, Japan. E-mail myokota{at}tsuru.med.nagoya-u.ac.jp
Background—Transforming growth
factor-ß (TGF-ß) is an important regulator of vascular remodeling
and is involved in the pathogenesis of atherosclerosis.
A T
C transition at nucleotide 29 of the
TGF-ß1 gene results in a LeuPro substitution
at amino acid 10 of the signal peptide. We have now examined a possible
association of TGF-ß1 genotype with myocardial
infarction (MI) in a Japanese population.
Methods and Results—TGF-ß1 genotype was determined in 315 Japanese patients (234 men and 81 women) with MI and 591 control subjects (289 men and 302 women). We found that age, body mass index, and incidence of habitual smoking, hypertension, diabetes mellitus, and hypercholesterolemia did not differ between the 2 groups for either men or women. Multivariable logistic regression analysis, however, demonstrated the frequency of the T allele to be significantly higher in male subjects with MI than in controls (TT + TC versus CC; P<0.0001, odds ratio 3.5, 95% CI 2.0 to 6.3). In contrast, the T allele was not associated with the prevalence of MI in women. In both male MI patients and controls, the serum concentration of TGF-ß1 was significantly higher in individuals with the CC genotype than in subjects with the TT or TC genotype.
Conclusions—Findings suggest that the T allele at nucleotide 29 in the TGF-ß1 gene is a risk factor for genetic susceptibility to MI, at least in middle-aged Japanese men.
Key Words: growth substances • genes • myocardial infarction • coronary disease
This article has been cited by other articles:
 |
|
 |
|
  C. P. Hersh, D. L. DeMeo, and E. K. Silverman National Emphysema Treatment Trial State of the Art: Genetics of Emphysema Proceedings of the ATS, May 1, 2008; 5(4): 486 - 493. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-J. Chang, C.-J. Chen, F.-C. Tsai, H.-M. Lai, P.-C. Tsai, M.-H. Tsai, and Y.-C. Ko Associations between gout tophus and polymorphisms 869T/C and -509C/T in transforming growth factor {beta}1 gene Rheumatology, May 1, 2008; 47(5): 617 - 621. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. S. Saltzman, J. F. Yamamoto, R. Decker, L. Yokochi, A. G. Theriault, T. M. Vogt, and L. Le Marchand Association of Genetic Variation in the Transforming Growth Factor {beta}-1 Gene with Serum Levels and Risk of Colorectal Neoplasia Cancer Res., February 15, 2008; 68(4): 1236 - 1244. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. I. Berndt, W.-Y. Huang, N. Chatterjee, M. Yeager, R. Welch, S. J. Chanock, J. L. Weissfeld, R. E. Schoen, and R. B. Hayes Transforming growth factor beta 1 (TGFB1) gene polymorphisms and risk of advanced colorectal adenoma Carcinogenesis, September 1, 2007; 28(9): 1965 - 1970. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Kang, K.-M. Lee, S. K. Park, S. I. Berndt, D. Reding, N. Chatterjee, R. Welch, S. Chanock, W.-Y. Huang, and R. B. Hayes Lack of Association of Transforming Growth Factor-{beta}1 Polymorphisms and Haplotypes with Prostate Cancer Risk in the Prostate, Lung, Colorectal, and Ovarian Trial Cancer Epidemiol. Biomarkers Prev., June 1, 2007; 16(6): 1303 - 1305. [Full Text] [PDF]
|
|
|
|
 |
|
 D. J. Grainger TGF-{beta} and atherosclerosis in man Cardiovasc Res, May 1, 2007; 74(2): 213 - 222. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Oda, N. Tanaka, T. Arai, J. Araki, Y. Song, L. Zhang, A. Kuchiba, T. Hosoi, T. Shirasawa, M. Muramatsu, et al. Polymorphisms in pro- and anti-inflammatory cytokine genes and susceptibility to atherosclerosis: a pathological study of 1503 consecutive autopsy cases Hum. Mol. Genet., March 15, 2007; 16(6): 592 - 599. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Kim and C. Lee The Gene Encoding Transforming Growth Factor {beta}1 Confers Risk of Ischemic Stroke and Vascular Dementia Stroke, November 1, 2006; 37(11): 2843 - 2845. [Full Text] [PDF]
|
|
|
|
|
|
M. P.S. Sie, A. G. Uitterlinden, M. J. Bos, P. P. Arp, M. M.B Breteler, P. J. Koudstaal, H. A.P. Pols, A. Hofman, C. M. van Duijn, and J. C.M. Witteman TGF-{beta}1 Polymorphisms and Risk of Myocardial Infarction and Stroke: The Rotterdam Study Stroke, November 1, 2006; 37(11): 2667 - 2671. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. S. Feigelson, A. V. Patel, W. R. Diver, V. L. Stevens, M. J. Thun, and E. E. Calle Transforming Growth Factor {beta} Receptor Type I and Transforming Growth Factor {beta}1 Polymorphisms Are Not Associated with Postmenopausal Breast Cancer. Cancer Epidemiol. Biomarkers Prev., June 1, 2006; 15(6): 1236 - 1237. [Full Text] [PDF]
|
|
|
|
 |
|
 J.-H. Mao, E. F. Saunier, J. P. de Koning, M. M. McKinnon, M. N. Higgins, K. Nicklas, H.-T. Yang, A. Balmain, and R. J. Akhurst Genetic variants of Tgfb1 act as context-dependent modifiers of mouse skin tumor susceptibility PNAS, May 23, 2006; 103(21): 8125 - 8130. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Koch, P. Hoppmann, J. C. Mueller, A. Schomig, and A. Kastrati Association of Transforming Growth Factor-{beta}1 Gene Polymorphisms With Myocardial Infarction in Patients With Angiographically Proven Coronary Heart Disease Arterioscler. Thromb. Vasc. Biol., May 1, 2006; 26(5): 1114 - 1119. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D L Mattey, N Nixon, P T Dawes, and J Kerr Association of polymorphism in the transforming growth factor {beta}1 gene with disease outcome and mortality in rheumatoid arthritis Ann Rheum Dis, August 1, 2005; 64(8): 1190 - 1194. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Shin, X.-O. Shu, Q. Cai, Y.-T. Gao, and W. Zheng Genetic Polymorphisms of the Transforming Growth Factor-{beta}1 Gene and Breast Cancer Risk: A Possible Dual Role at Different Cancer Stages Cancer Epidemiol. Biomarkers Prev., June 1, 2005; 14(6): 1567 - 1570. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T Hamaguchi, S Okino, N Sodeyama, Y Itoh, A Takahashi, E Otomo, M Matsushita, H Mizusawa, and M Yamada Association of a polymorphism of the transforming growth factor-{beta}1 gene with cerebral amyloid angiopathy J. Neurol. Neurosurg. Psychiatry, May 1, 2005; 76(5): 696 - 699. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. G. Kaklamani, L. Baddi, J. Liu, D. Rosman, S. Phukan, C. Bradley, C. Hegarty, B. McDaniel, A. Rademaker, C. Oddoux, et al. Combined Genetic Assessment of Transforming Growth Factor-{beta} Signaling Pathway Variants May Predict Breast Cancer Risk Cancer Res., April 15, 2005; 65(8): 3454 - 3461. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. M. Ulrich, J. Whitton, J.-H. Yu, J. Sibert, R. Sparks, J. D. Potter, and J. Bigler PTGS2 (COX-2) -765G > C Promoter Variant Reduces Risk of Colorectal Adenoma among Nonusers of Nonsteroidal Anti-inflammatory Drugs Cancer Epidemiol. Biomarkers Prev., March 1, 2005; 14(3): 616 - 619. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Sparks, J. Bigler, J. G Sibert, J. D Potter, Y. Yasui, and C. M Ulrich TGF{beta}1 polymorphism (L10P) and risk of colorectal adenomatous and hyperplastic polyps Int. J. Epidemiol., October 1, 2004; 33(5): 955 - 961. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Ewart-Toland, J. M. Chan, J. Yuan, A. Balmain, and J. Ma A Gain of Function TGFB1 Polymorphism May Be Associated With Late Stage Prostate Cancer Cancer Epidemiol. Biomarkers Prev., May 1, 2004; 13(5): 759 - 764. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. L. Marchand, C. A. Haiman, D. van den Berg, L. R. Wilkens, L. N. Kolonel, and B. E. Henderson T29C Polymorphism in the Transforming Growth Factor {beta}1 Gene and Postmenopausal Breast Cancer Risk: The Multiethnic Cohort Study Cancer Epidemiol. Biomarkers Prev., March 1, 2004; 13(3): 412 - 415. [Abstract] [Full Text]
|
|
|
|
|
|
D. J. Grainger Transforming Growth Factor {beta} and Atherosclerosis: So Far, So Good for the Protective Cytokine Hypothesis Arterioscler. Thromb. Vasc. Biol., March 1, 2004; 24(3): 399 - 404. [Abstract] [Full Text]
|
|
|
|
|
|
X.-O. Shu, Y.-T. Gao, Q. Cai, L. Pierce, H. Cai, Z.-X. Ruan, G. Yang, F. Jin, and W. Zheng Genetic Polymorphisms in the TGF-{beta}1 Gene and Breast Cancer Survival: A Report from the Shanghai Breast Cancer Study Cancer Res., February 1, 2004; 64(3): 836 - 839. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Li, T. Habuchi, N. Tsuchiya, K. Mitsumori, L. Wang, C. Ohyama, K. Sato, T. Kamoto, O. Ogawa, and T. Kato Increased risk of prostate cancer and benign prostatic hyperplasia associated with transforming growth factor-beta 1 gene polymorphism at codon10 Carcinogenesis, February 1, 2004; 25(2): 237 - 240. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Tang, M. L. McKinnon, L. M. Leong, S. A. B. Rusholme, S. Wang, and R. J. Akhurst Genetic modifiers interact with maternal determinants in vascular development of Tgfb1-/- mice Hum. Mol. Genet., July 1, 2003; 12(13): 1579 - 1589. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Dunning, P. D. Ellis, S. McBride, H. L Kirschenlohr, C. S. Healey, P. R. Kemp, R. N. Luben, J. Chang-Claude, A. Mannermaa, V. Kataja, et al. A Transforming Growth Factor{beta}1 Signal Peptide Variant Increases Secretion in Vitro and Is Associated with Increased Incidence of Invasive Breast Cancer Cancer Res., May 15, 2003; 63(10): 2610 - 2615. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Chen, D. Li, T. Saldeen, and J. L. Mehta TGF-beta 1 attenuates myocardial ischemia-reperfusion injury via inhibition of upregulation of MMP-1 Am J Physiol Heart Circ Physiol, May 1, 2003; 284(5): H1612 - H1617. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y Sugiura, T Niimi, S Sato, T Yoshinouchi, S Banno, T Naniwa, H Maeda, S Shimizu, and R Ueda Transforming growth factor {beta}1 gene polymorphism in rheumatoid arthritis Ann Rheum Dis, September 1, 2002; 61(9): 826 - 828. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F Andreotti, I Porto, F Crea, and A Maseri Inflammatory gene polymorphisms and ischaemic heart disease: review of population association studies Heart, February 1, 2002; 87(2): 107 - 112. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. SASAOKA, A. KIMURA, S. HOHTA, N. FUKUDA, T. KUROSAWA, and T. IZUMI Polymorphisms in the Platelet-Endothelial Cell Adhesion Molecule-1 (PECAM-1) Gene, Asn563Ser and Gly670Arg, Associated with Myocardial Infarction in the Japanese Ann. N.Y. Acad. Sci., December 1, 2001; 947(1): 259 - 270. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Rivera, M. Echegaray, T. Rankinen, L. Perusse, T. Rice, J. Gagnon, A. S. Leon, J. S. Skinner, J. H. Wilmore, D. C. Rao, et al. TGF-{beta}1 gene-race interactions for resting and exercise blood pressure in the HERITAGE Family Study J Appl Physiol, October 1, 2001; 91(4): 1808 - 1813. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Ziv, J. Cauley, P. A. Morin, R. Saiz, and W. S. Browner Association Between the T29->C Polymorphism in the Transforming Growth Factor {beta}1 Gene and Breast Cancer Among Elderly White Women: The Study of Osteoporotic Fractures JAMA, June 13, 2001; 285(22): 2859 - 2863. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Armstrong Genetic Susceptibility to Breast Cancer: From the Roll of the Dice to the Hand Women Were Dealt JAMA, June 13, 2001; 285(22): 2907 - 2909. [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Mallat, A. Gojova, C. Marchiol-Fournigault, B. Esposito, C. Kamate, R. Merval, D. Fradelizi, and A. Tedgui Inhibition of Transforming Growth Factor-{beta} Signaling Accelerates Atherosclerosis and Induces an Unstable Plaque Phenotype in Mice Circ. Res., November 9, 2001; 89(10): 930 - 934. [Abstract] [Full Text] [PDF]
|
|